The Nanomedicine Initiative has two major goals: 1) understand how the biological machinery inside living cells is built and operates at the nanoscale and, 2) use this information to re-engineer these structures, develop new technologies that could be applied to treating diseases, and/or leverage the new knowledge to focus work directly on translational studies to treat a disease or repair damaged tissue. The program began in 2005 with a national network of eight Nanomedicine Development Centers. Now, in the second half of this 10-year program, the four centers best positioned to effectively apply their findings to translational studies were selected to continue receiving support.
Read more...